XML 30 R5.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
6 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Operating activities:    
Net income (loss) $ 6,400,000 $ (4,214,000)
Adjustments to reconcile net income (loss) to net cash from operating activities:    
Depreciation and amortization 10,058,000 10,501,000
Amortization of deferred gain (213,000) (437,000)
Loss on sale of fixed assets 177,000 0
Equity in earnings of joint venture (5,841,000) (2,314,000)
Dividends from joint venture 1,336,000 338,000
Deferred tax benefit (1,501,000) (7,063,000)
Share-based compensation expense 1,906,000 1,020,000
Excess tax benefits from share-based payment arrangements (145,000) (166,000)
Increase (decrease) from changes in:    
Accounts receivable (33,420,000) (28,109,000)
Inventories (41,920,000) 287,000
Prepaid expenses and other current assets (593,000) (889,000)
Other assets 15,000 2,221,000
Prepaid pension costs (920,000) (524,000)
Accounts payable 47,768,000 23,529,000
Accrued liabilities (6,004,000) 2,763,000
Income taxes payable and receivable 6,194,000 5,504,000
Postretirement benefit obligations and other liabilities 165,000 229,000
Net cash (used in) from operating activities (16,538,000) 2,676,000
Investing activities:    
Capital expenditures (4,819,000) (3,254,000)
Proceeds from sale of fixed assets 64,000 0
Net cash used in investing activities (4,755,000) (3,254,000)
Financing activities:    
Short-term borrowings (repayments), net 15,163,000 (2,602,000)
Net borrowings on long-term revolving lines of credit 1,616,000 1,469,000
Repayments of long-term debt (214,000) (350,000)
Excess tax benefits from share-based payment arrangements 145,000 166,000
Exercise of stock options 240,000 244,000
Net cash from (used in) financing activities 16,950,000 (1,073,000)
Effect of exchange rate changes on cash and cash equivalents (307,000) (254,000)
Net decrease in cash and cash equivalents (4,650,000) (1,905,000)
Cash and cash equivalents - beginning of year 36,716,000 28,311,000
Cash and cash equivalents - end of period $ 32,066,000 $ 26,406,000